Effective Treatment of CNS Metastasis in Sarcomatoid Renal Cell Carcinoma
Author Information
Author(s): Beier Dagmar, Schuierer Gerhard, Beier Christoph P, Bogdahn Ulrich
Primary Institution: Department of Neurology, Medical School, University of Regensburg and District Medical Center Regensburg
Hypothesis
Can a combination of temozolomide and pegylated liposomal doxorubicin effectively treat CNS metastasis of sarcomatoid renal cell carcinoma?
Conclusion
The combination of temozolomide and pegylated liposomal doxorubicin led to nearly complete remission of CNS metastases in a patient with sarcomatoid renal cell carcinoma.
Supporting Evidence
- The patient showed marked improvement after starting the new chemotherapy regimen.
- Imaging studies indicated nearly complete remission of intracranial metastases after treatment.
Takeaway
A patient with a serious type of kidney cancer had a big improvement after taking two special medicines together.
Methodology
The patient received chemotherapy with temozolomide and pegylated liposomal doxorubicin, along with other supportive treatments.
Limitations
The treatment was not completed due to severe side effects and the patient ultimately passed away due to disease progression.
Participant Demographics
63-year-old female, Caucasian.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website